investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Epigenetic regulation by microRNA of MDS pathogenesis
Keisuke Ito
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
No posts
Related projects
Alan B. Cantor
Regulation of RUNX1 Multiprotein Complex Formation during Hematopoiesis
Leukaemia
Hematology and hematologic malignancies
Guy S Salvesen
IAP Family Proteins and Cancer
Leukaemia
Hematology and hematologic malignancies
Alan Rein
Retrovirus Assembly and Maturation - Rockville
Leukaemia
Hematology and hematologic malignancies
Tomasz Skorski
BCR/ABL-PI-3k-ROS pathway induce genomic instability ....
Leukaemia
Hematology and hematologic malignancies
Jeffrey S Miller
Viral priming and targeting NK cells against solid tumor malignancies
Leukaemia
Hematology and hematologic malignancies
James Kochenderfer
Autologous T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor
Leukaemia
Hematology and hematologic malignancies
Catherine Ju-Ying Wu
(PQD1) Impact of Cytotoxic and Targeted Therapy on Clonal Evolution of CLL
Leukaemia
Hematology and hematologic malignancies
Clark W Distelhorst
Targeting PKM2-InsP3R interaction to treat AML
Leukaemia
Hematology and hematologic malignancies
Nora C Heisterkamp
Role of Sialic Acid Modification in ALL Survival and Drug Resistance
Leukaemia
Hematology and hematologic malignancies
